Stock FRTX FRESH TRACKS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Fresh Tracks Therapeutics, Inc.

Equities

FRTX

US10802T2042

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 01:44:55 2024-05-15 pm EDT 		5-day change 1st Jan Change
0.9 USD -1.10% Intraday chart for Fresh Tracks Therapeutics, Inc. -4.15% +2.38%
Mar. 15 Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index CI

Business Summary

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Number of employees: 4

Sales per Business

USD in Million2022Weight2023Weight Delta
Prescription Therapeutics
100.0 %
7 100.0 % 8 100.0 % +15.31%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
7 100.0 % 8 100.0 % +15.31%

Managers

Managers TitleAgeSince
Albert Marchio CEO
 Chief Executive Officer 72 20-11-30
Nancy Seretta CTO
 Chief Tech/Sci/R&D Officer - 15-12-31
Aaron Fox-Collis AUD
 Comptroller/Controller/Auditor - 20-06-30
Aron Aizenstat PRN
 Corporate Officer/Principal - -
Sue Fattor HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Albert Marchio CEO
 Chief Executive Officer 72 20-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,973,306 5,877,545 ( 98.40 %) 0 98.40 %

Shareholders

NameEquities%Valuation
Exploration Capital LLC
21.31 %
1,273,024 21.31 % 1 M $
Telemetry Investments LLC
1.088 %
65,000 1.088 % 59 865 $
Stephen L Gustin
0.7868 %
47,000 0.7868 % 43 287 $
Deepak Chadha
0.3736 %
22,314 0.3736 % 20 551 $
David McAvoy
0.2741 %
16,371 0.2741 % 15 078 $
Robert Brown
0.1178 %
7,034 0.1178 % 6 478 $
ANGES, INC.
0.1094 %
6,535 0.1094 % 6 019 $
Merrill Lynch Investment Managers, Inc.
0.001607 %
96 0.001607 % 88 $
Old Point Trust & Financial Services, NA
0.000737 %
44 0.000737 % 41 $
Nordea Investment Management AB
0.000084 %
5 0.000084 % 5 $

Company contact information

Fresh Tracks Therapeutics, Inc.

5777 Central Avenue Suite 102

80301, Boulder

+

http://www.frtx.com
address Fresh Tracks Therapeutics, Inc.(FRTX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
FRESH TRACKS THERAPEUTICS, INC. Stock Fresh Tracks Therapeutics, Inc.
+2.38% 5.44M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+7.38% 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.22% 106B
BIONTECH SE Stock BioNTech SE
-12.46% 22.24B
ARGENX SE Stock argenx SE
+0.44% 21.25B
GENMAB A/S Stock Genmab A/S
-4.18% 18.97B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.85% 18.52B
BEIGENE, LTD. Stock BeiGene, Ltd.
-8.56% 16.81B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.65% 12.54B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-24.21% 8.09B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. FRTX Stock
  4. Company Fresh Tracks Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW